Drug Interactions between indomethacin and Mitigare
This report displays the potential drug interactions for the following 2 drugs:
- indomethacin
- Mitigare (colchicine)
Interactions between your drugs
There were no interactions found between indomethacin and Mitigare. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
indomethacin
A total of 429 drugs are known to interact with indomethacin.
- Indomethacin is in the drug class Nonsteroidal anti-inflammatory drugs.
- Indomethacin is used to treat the following conditions:
Mitigare
A total of 312 drugs are known to interact with Mitigare.
- Mitigare is in the drug class antigout agents.
- Mitigare is used to treat the following conditions:
Drug and food/lifestyle interactions
colchicine food/lifestyle
Applies to: Mitigare (colchicine)
Drinking large amounts of grapefruit juice can increase your blood levels of colchicine to dangerous levels. You should avoid the consumption of grapefruit or grapefruit juice during treatment with colchicine. Let your doctor know if you experience abdominal pain, nausea, vomiting, diarrhea, fever, muscle pain, weakness, fatigue, and/or numbness or tingling in your hands and feet, as these may be early symptoms of colchicine toxicity.
indomethacin food/lifestyle
Applies to: indomethacin
Ask your doctor before using indomethacin together with ethanol (alcohol). Do not drink alcohol while taking indomethacin. Alcohol can increase your risk of stomach bleeding caused by indomethacin. Call your doctor at once if you have symptoms of bleeding in your stomach or intestines. This includes black, bloody, or tarry stools, or coughing up blood or vomit that looks like coffee grounds. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.